New Drug for MS, Insulin and Alzheimer's, Dexamethasone and Myopathy,Teen Migraines
A new investigational drug, FTY720, has demonstrated a 70% reduction in relapse in a study of 3000 patients with multiple sclerosis. Abnormal acute insulin release is linked to an increased risk for Alzheimer's disease. Dexamethasone pulse therapy offers an improved side effect profile compared to prednisone treatment of acute inflammatory myopathy. And divalproex treatment of migraine in teens offers mixed results.
Right click on the icon with the format of your choice (MP3 or Windows Media) and select "Save Target As..." or "Save Link As..." to download the file to your MP3 player or computer. Click on the grey arrow below to listen on your computer.
File Size: 16.56 MB Playtime: 18:04
Subscribe directly using your preferred podcasting tool:
Or, copy and paste this URL into a podcasting tool:
